Ironwood Investment Counsel LLC reduced its position in Colgate-Palmolive (NYSE:CL – Free Report) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,727 shares of the company’s stock after selling 254 shares during the quarter. Ironwood Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $612,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $33,000. 80.41% of the stock is owned by institutional investors.
Colgate-Palmolive Price Performance
Shares of NYSE:CL opened at $89.80 on Friday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The stock has a fifty day moving average of $89.02 and a 200-day moving average of $94.82. The company has a market capitalization of $72.87 billion, a PE ratio of 25.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.
Analysts Set New Price Targets
Several equities analysts have recently commented on CL shares. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. UBS Group reduced their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Barclays reduced their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Raymond James reiterated an “outperform” rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $101.72.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What is the Shanghai Stock Exchange Composite Index?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.